During her session at the Hospitality Operator Forum, Catherine Beike, CEO of Essendi, spoke about the company's ...

The Washington Commanders' new uniforms are an ode to when the franchise won three Super Bowls between the 1982 and 1991 ...

“Adidem” is a Latin term that means “to the same thing” or “meeting of the minds.” Bruno chose the word because of the ...

The St. Louis Cardinals baseball team has its own iconic “STL” logo, and now the Blues have their own distinctive mark with ...

Ascendis Pharma A/S (Nasdaq: ASND) today announced two oral presentations at ENDO 2025, the annual meeting of the Endocrine ...

COPENHAGEN, Denmark, May 01, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (ASND) today announced financial results for the first quarter ended March 31, 2025, and provided a business update ...

Ascendis Pharma will also host a conference call and live webcast on May 1, 2025, at 4:30 p.m. Eastern Time (ET) to discuss its first quarter 2025 financial results.

Guided by its core values of Patients, Science, and Passion, Ascendis uses its TransCon technologies to create new and potentially best-in-class therapies.

Ascendis Pharma is applying its innovative TransCon technology platform to build a leading, fully integrated biopharma company focused on making a meaningful difference in patients' lives. Guided by ...

Ascendis Pharma UK, a subsidiary of the global biopharmaceutical company with a portfolio of products and product candidates specialising in rare endocrine diseases, has opened a UK office and ...

Ascendis Pharma UK, a subsidiary of the global biopharmaceutical company with a portfolio of products and product candidates specialising in rare endocrine diseases, has opened a UK office and ...

BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that the company has initiated a legal action against Ascendis Pharma A/S for infringement of European patent EP 3 175 863 B1 at the ...